We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Dental Stocks' Earnings Roster for Nov 2: ABC, HSIC, HYH
Read MoreHide Full Article
The current week is set to see a plethora of earnings releases as many bigwigs are lined up to report their quarterly numbers. Notably, the Q3 earnings season is projected to be the first quarter to see positive earnings growth after five consecutive quarters of decline.
As per the latest Earnings Preview, 291 S&P companies have already disclosed their numbers as of Oct 28. Notably, reported earnings increased 2.2% year over year on a 1.3% surge in revenues, with the beat ratio being 73.5% for earnings and 57.4% for revenues.
Medical is one of the major broader sectors among the 16 Zacks sectors in the S&P 500 cohort that is expected to report earnings growth in the third quarter. The sector is likely to report earnings growth of 6% on revenue improvement of 7.3%.
Dental is an important component of the Medical sector and is expected follow the same earnings growth trajectory in the quarter. Here, we take a look at three Dental stocks set to report their quarterly figures on Nov 2:
Chesterbrook, PA-based AmerisourceBergen Corporation is set to report fourth-quarter and fiscal 2016 results before the opening bell. AmerisourceBergen is one of the world’s largest pharmaceutical services companies, which focuses on providing drug distribution and related services to reduce health care costs and improve patient outcomes.
AmerisourceBergen’s track record has been quite promising, with the company comfortably beating estimates in three of the four trailing quarters. However, headwinds in the form of contract renewals and lower generic inflation are likely to mar opportunities for AmerisourceBergen. On the brighter side, the company extended its ties with the largest health systems customer for an additional five years earlier this year, which is expected to prove accretive.
As per our model, a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) to beat earnings. Simultaneously, we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Headquartered in Melville, NY, Henry Schein Inc. (HSIC - Free Report) is scheduled to report third-quarter 2016 financial numbers before the opening bell. The company is a leading distributor of health care products and services across the globe.
Last quarter, the company registered a positive earnings surprise of 1.23%. In fact, Henry Schein’s earnings surpassed the Zacks Consensus Estimate in the past four quarters, at an average of 2.51%
Headwinds in the form of increased competition in the medical product distribution market, market uncertainties and lower-than expected Dental Sales are major concerns. However, solid returns from the Medical, Animal Health and Technology and Value-Added Services businesses and the company’s ability to win new customers in the medical space holds considerable promise for Henry Schein (read more: Henry Schein Q3 Earnings: Disappointment in Store?).
Nevertheless, our proven model does not conclusively show that the company is likely to beat earnings, given the combination of a Zacks Rank #4 and earnings ESP of -0.61%. Please check our Earnings ESP Filter that enables you to find stocks that are expected to come out with earnings surprises.
Headquartered in Alpharetta, GA, Halyard Health Inc. is scheduled to report third-quarter earnings before the market opens. The company is primarily focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery actions.
Halyard Health posted a positive earnings surprise in the last four trailing quarters, the average being 25.8%. However, in the last quarter, the company missed the Zacks Consensus Estimate in terms of revenue by $64 million. Meanwhile, Halyard Health has withdrawn the previously issued financial guidance for 2016, as a result of the divestiture of the Total Population Health Services (TPHS) business unit to ShareCare.
Meanwhile, our proven model does not conclusively show that the company is likely to beat earnings, given the combination of a Zacks Rank #4 and earnings ESP of 0.00%.
While the above ideas are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trades >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Dental Stocks' Earnings Roster for Nov 2: ABC, HSIC, HYH
The current week is set to see a plethora of earnings releases as many bigwigs are lined up to report their quarterly numbers. Notably, the Q3 earnings season is projected to be the first quarter to see positive earnings growth after five consecutive quarters of decline.
As per the latest Earnings Preview, 291 S&P companies have already disclosed their numbers as of Oct 28. Notably, reported earnings increased 2.2% year over year on a 1.3% surge in revenues, with the beat ratio being 73.5% for earnings and 57.4% for revenues.
Medical is one of the major broader sectors among the 16 Zacks sectors in the S&P 500 cohort that is expected to report earnings growth in the third quarter. The sector is likely to report earnings growth of 6% on revenue improvement of 7.3%.
Dental is an important component of the Medical sector and is expected follow the same earnings growth trajectory in the quarter. Here, we take a look at three Dental stocks set to report their quarterly figures on Nov 2:
Chesterbrook, PA-based AmerisourceBergen Corporation is set to report fourth-quarter and fiscal 2016 results before the opening bell. AmerisourceBergen is one of the world’s largest pharmaceutical services companies, which focuses on providing drug distribution and related services to reduce health care costs and improve patient outcomes.
AMERISOURCEBRGN Price and EPS Surprise
AMERISOURCEBRGN Price and EPS Surprise | AMERISOURCEBRGN Quote
AmerisourceBergen’s track record has been quite promising, with the company comfortably beating estimates in three of the four trailing quarters. However, headwinds in the form of contract renewals and lower generic inflation are likely to mar opportunities for AmerisourceBergen. On the brighter side, the company extended its ties with the largest health systems customer for an additional five years earlier this year, which is expected to prove accretive.
As per our model, a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) to beat earnings. Simultaneously, we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Thus, the company is not likely to beat earnings, given the combination of a Zacks Rank #4 (Sell) and an Earnings ESP of -0.82% (read more: AmerisourceBergen Q3 Earnings: Will It Disappoint?).
Headquartered in Melville, NY, Henry Schein Inc. (HSIC - Free Report) is scheduled to report third-quarter 2016 financial numbers before the opening bell. The company is a leading distributor of health care products and services across the globe.
Last quarter, the company registered a positive earnings surprise of 1.23%. In fact, Henry Schein’s earnings surpassed the Zacks Consensus Estimate in the past four quarters, at an average of 2.51%
HENRY SCHEIN IN Price and EPS Surprise
HENRY SCHEIN IN Price and EPS Surprise | HENRY SCHEIN IN Quote
Headwinds in the form of increased competition in the medical product distribution market, market uncertainties and lower-than expected Dental Sales are major concerns. However, solid returns from the Medical, Animal Health and Technology and Value-Added Services businesses and the company’s ability to win new customers in the medical space holds considerable promise for Henry Schein (read more: Henry Schein Q3 Earnings: Disappointment in Store?).
Nevertheless, our proven model does not conclusively show that the company is likely to beat earnings, given the combination of a Zacks Rank #4 and earnings ESP of -0.61%. Please check our Earnings ESP Filter that enables you to find stocks that are expected to come out with earnings surprises.
Headquartered in Alpharetta, GA, Halyard Health Inc. is scheduled to report third-quarter earnings before the market opens. The company is primarily focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery actions.
Halyard Health posted a positive earnings surprise in the last four trailing quarters, the average being 25.8%. However, in the last quarter, the company missed the Zacks Consensus Estimate in terms of revenue by $64 million. Meanwhile, Halyard Health has withdrawn the previously issued financial guidance for 2016, as a result of the divestiture of the Total Population Health Services (TPHS) business unit to ShareCare.
HALYARD HEALTH Price and EPS Surprise
HALYARD HEALTH Price and EPS Surprise | HALYARD HEALTH Quote
Meanwhile, our proven model does not conclusively show that the company is likely to beat earnings, given the combination of a Zacks Rank #4 and earnings ESP of 0.00%.
You can see the complete list of today’s Zacks #1 Rank stocks here
Now See Our Private Investment Ideas
While the above ideas are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trades >>